共 50 条
Effect of anti-COVID-19 drugs on patients with cancer
被引:1
|作者:
Huang, Weicai
[1
]
Liu, Wenyu
[1
]
Yu, Tingting
[1
]
Zhang, Zhaoyang
[1
]
Zhai, Lingyun
[2
]
Huang, Panpan
[1
]
Lu, Yao
[1
]
机构:
[1] Gannan Med Univ, Sch Basic Med, Ganzhou 341000, Jiangxi, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 2, Gynecol Dept, Sch Med, Hangzhou 310009, Zhejiang, Peoples R China
关键词:
Cancer;
COVID-19;
Drugs;
Tumor progression;
GAMMA INHIBITS GROWTH;
INTERFERON-GAMMA;
LUNG-CANCER;
COVID-19;
SEVERITY;
CARCINOMA-CELLS;
RISK-FACTORS;
IFN-GAMMA;
T-CELLS;
RIBAVIRIN;
TOCILIZUMAB;
D O I:
10.1016/j.ejmech.2024.116214
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
The clinical treatment of patients with cancer who are also diagnosed with coronavirus disease (COVID-19) has been a challenging issue since the outbreak of COVID-19. Therefore, it is crucial to understand the effects of commonly used drugs for treating COVID-19 in patients with cancer. Hence, this review aims to provide a reference for the clinical treatment of patients with cancer to minimize the losses caused by the COVID-19 pandemic. In this study, we also focused on the relationship between COVID-19, commonly used drugs for treating COVID-19, and cancer. We specifically investigated the effect of these drugs on tumor cell proliferation, migration, invasion, and apoptosis. The potential mechanisms of action of these drugs were discussed and evaluated. We found that most of these drugs showed inhibitory effects on tumors, and only in a few cases had cancer-promoting effects. Furthermore, inappropriate usage of these drugs may lead to irreversible kidney and heart damage. Finally, we have clarified the use of different drugs, which can provide useful guidance for the clinical treatment of cancer patients diagnosed with COVID-19.
引用
收藏
页数:12
相关论文